PT98325A - Processo para a preparacao de comprimidos e de granulado que contem como substancia activa o 2-mercaptoetanossulfonato de sodio (mesna) - Google Patents
Processo para a preparacao de comprimidos e de granulado que contem como substancia activa o 2-mercaptoetanossulfonato de sodio (mesna)Info
- Publication number
- PT98325A PT98325A PT98325A PT9832591A PT98325A PT 98325 A PT98325 A PT 98325A PT 98325 A PT98325 A PT 98325A PT 9832591 A PT9832591 A PT 9832591A PT 98325 A PT98325 A PT 98325A
- Authority
- PT
- Portugal
- Prior art keywords
- mesna
- tablets
- weight
- parts
- mercaptoethanosulphonate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Glanulating (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4022525 | 1990-07-16 | ||
SG142394A SG142394G (en) | 1990-07-16 | 1994-10-03 | Tablet and granulate containing mesna as active agent |
Publications (2)
Publication Number | Publication Date |
---|---|
PT98325A true PT98325A (pt) | 1992-05-29 |
PT98325B PT98325B (pt) | 1999-01-29 |
Family
ID=25895027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT98325A PT98325B (pt) | 1990-07-16 | 1991-07-15 | Processo para a preparacao de comprimidos e de granulado que contem como substancia activa o 2-mercaptoetanossulfonato de sodio (mesna) |
Country Status (31)
Country | Link |
---|---|
US (1) | US5262169A (pt) |
EP (1) | EP0468245B1 (pt) |
JP (1) | JP3068894B2 (pt) |
KR (1) | KR100189666B1 (pt) |
CN (1) | CN1072484C (pt) |
AT (1) | ATE104548T1 (pt) |
AU (1) | AU638586B2 (pt) |
BG (2) | BG60851B1 (pt) |
CA (1) | CA2047027C (pt) |
DE (2) | DE4122167A1 (pt) |
DK (1) | DK0468245T3 (pt) |
EG (1) | EG20019A (pt) |
ES (1) | ES2063412T3 (pt) |
FI (1) | FI97949C (pt) |
HK (1) | HK129894A (pt) |
HR (1) | HRP920889B1 (pt) |
HU (1) | HU206630B (pt) |
IE (1) | IE65373B1 (pt) |
IL (1) | IL98836A (pt) |
LT (1) | LT3527B (pt) |
LV (1) | LV10040B (pt) |
MC (1) | MC2273A1 (pt) |
MX (1) | MX174407B (pt) |
NO (1) | NO178362C (pt) |
NZ (1) | NZ238941A (pt) |
PT (1) | PT98325B (pt) |
RO (1) | RO113713B1 (pt) |
RU (1) | RU2070040C1 (pt) |
SG (1) | SG142394G (pt) |
SI (1) | SI9111226A (pt) |
ZA (1) | ZA915515B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2111659T3 (es) * | 1992-03-11 | 1998-03-16 | Asta Medica Ag | Comprimidos, granulados y nodulos con alto contenido en sustancias activas para formas de administracion solidas de alta concentracion. |
US5773031A (en) * | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
DE19733305A1 (de) * | 1997-08-01 | 1999-02-04 | Asta Medica Ag | Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin |
EP0955040A1 (de) * | 1998-04-27 | 1999-11-10 | ASTA Medica Aktiengesellschaft | Arzneiform zur oralen Applikation von Mesna |
DE19826517B4 (de) * | 1998-06-15 | 2006-03-23 | Baxter Healthcare S.A. | Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette |
US6075053A (en) * | 1999-02-09 | 2000-06-13 | Bionumerik Pharmaceuticals, Inc. | Method of reducing or reversing neuropathy |
WO2009022430A1 (en) * | 2007-08-10 | 2009-02-19 | Ki Pharmaceuticals, Inc. | Skin whitening agent |
CA2936741C (en) | 2014-10-31 | 2018-11-06 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4734418A (en) * | 1984-12-14 | 1988-03-29 | Mitsui Petrochemical Industries, Ltd. | Quinazoline compounds and antihypertensives |
IT1185551B (it) * | 1985-04-15 | 1987-11-12 | Schering Spa | Composizioni farmaceutiche a base di acido mercaptoetansolfonico ad attivita' terapeutica,derivati salini organici dell'acido mercaptoetansolfonico utili per tali composizioni e relativo procedimento di preparazione |
EP0334083B1 (de) * | 1988-03-19 | 1991-07-24 | ASTA Pharma Aktiengesellschaft | Ifosfamid-Mesna-Lyophilisat und Verfahren zu dessen Herstellung |
-
1991
- 1991-07-04 DE DE4122167A patent/DE4122167A1/de not_active Withdrawn
- 1991-07-04 AT AT9191111125T patent/ATE104548T1/de not_active IP Right Cessation
- 1991-07-04 DE DE59101431T patent/DE59101431D1/de not_active Expired - Lifetime
- 1991-07-04 DK DK91111125.0T patent/DK0468245T3/da active
- 1991-07-04 EP EP91111125A patent/EP0468245B1/de not_active Expired - Lifetime
- 1991-07-04 ES ES91111125T patent/ES2063412T3/es not_active Expired - Lifetime
- 1991-07-11 MC MC912205A patent/MC2273A1/xx unknown
- 1991-07-11 MX MX9100169A patent/MX174407B/es unknown
- 1991-07-11 RU SU915001036A patent/RU2070040C1/ru active
- 1991-07-12 SI SI9111226A patent/SI9111226A/sl unknown
- 1991-07-12 JP JP3172291A patent/JP3068894B2/ja not_active Expired - Lifetime
- 1991-07-12 NZ NZ238941A patent/NZ238941A/en not_active IP Right Cessation
- 1991-07-14 EG EG42391A patent/EG20019A/xx active
- 1991-07-15 RO RO148005A patent/RO113713B1/ro unknown
- 1991-07-15 PT PT98325A patent/PT98325B/pt not_active IP Right Cessation
- 1991-07-15 NO NO912771A patent/NO178362C/no not_active IP Right Cessation
- 1991-07-15 KR KR1019910012014A patent/KR100189666B1/ko not_active IP Right Cessation
- 1991-07-15 HU HU912374A patent/HU206630B/hu unknown
- 1991-07-15 AU AU80445/91A patent/AU638586B2/en not_active Expired
- 1991-07-15 ZA ZA915515A patent/ZA915515B/xx unknown
- 1991-07-15 IE IE246391A patent/IE65373B1/en not_active IP Right Cessation
- 1991-07-15 CN CN91104805A patent/CN1072484C/zh not_active Expired - Lifetime
- 1991-07-15 FI FI913409A patent/FI97949C/fi not_active IP Right Cessation
- 1991-07-15 IL IL9883691A patent/IL98836A/en not_active IP Right Cessation
- 1991-07-15 CA CA002047027A patent/CA2047027C/en not_active Expired - Lifetime
- 1991-07-16 US US07/730,178 patent/US5262169A/en not_active Expired - Lifetime
- 1991-07-16 BG BG94824A patent/BG60851B1/bg unknown
-
1992
- 1992-04-08 BG BG96200A patent/BG60901B1/bg unknown
- 1992-10-02 HR HRP-1226/91A patent/HRP920889B1/xx not_active IP Right Cessation
- 1992-10-27 LV LVP-92-168A patent/LV10040B/lv unknown
-
1993
- 1993-09-03 LT LTIP920A patent/LT3527B/lt not_active IP Right Cessation
-
1994
- 1994-10-03 SG SG142394A patent/SG142394G/en unknown
- 1994-11-24 HK HK129894A patent/HK129894A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2061623T3 (es) | Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico. | |
GR3004643T3 (pt) | ||
UA26455C2 (uk) | Лікарський препарат у формі таблеток із сповільhеhим вивільhеhhям активhого іhгредієhта | |
PE19496A1 (es) | Formulacion de analogo de insulina humana | |
ES2068800T3 (es) | Preparacion farmaceutica en forma de un comprimido efervescente y/o de descomposicion, o de un granulado instantaneo, asi como procedimiento para su fabricacion. | |
PT91108A (pt) | Processo para a preparacao de uma composicao farmaceutica que compreende um ingrediente activo tal como um sal do acido colico e um produto inibidor para activar a absorcao do ingrediente activo pelo corpo humano | |
PT98325A (pt) | Processo para a preparacao de comprimidos e de granulado que contem como substancia activa o 2-mercaptoetanossulfonato de sodio (mesna) | |
DE3267039D1 (en) | Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle | |
ES2029776T3 (es) | Procedimiento para la preparacion de composiciones farmaceuticas que contienen bromocriptina con gran estabilidad y productos relacionados. | |
BR9913782A (pt) | Processo de preparação de uma formualação galênica que compreende fenofibrato como princìpio ativo, formulação galênica, medicamento e utilizações de um meio lìquido e de partìculas de fenofibrato | |
PT82512B (pt) | Processo para a preparacao de derivados de quinolilglicinamidas com actividade psicotropica e de composicoes farmaceuticas que os contem | |
GB2021409A (en) | Pharmaceutical composition | |
MX172107B (es) | Procedimiento para la desinfeccion de masas para vaciado medicinales | |
ES556437A0 (es) | Procedimiento para preparar un agente que contiene tirosina o un derivado de tirosina como sustancia activa para mejorar la fecundidad de mamiferos. | |
YU122691A (sh) | Tablete i granulat koji kao aktivnu materiju sadrže natrijum-2-merkapto-etansulfonat | |
ES2077193T3 (es) | Procedimiento de esterificacion de acidos hidroxibenzoicos. | |
ES2118845T3 (es) | Proceso para la preparacion de trimetilaluminio por reaccion de cloruros de metilaluminio con sodio en reactores de estado solido. | |
SE8401856D0 (sv) | New pharmaceutical preparations | |
GB1166958A (en) | Process for Making Tablets Containing Aspirin and Salicylamide | |
YU46792B (sh) | Kipuća tableta za dezinfekciju vode na bazi hloramina i postupak za njihovu proizvodnju | |
JPS5615208A (en) | Remedy for trichophytosis | |
JI et al. | THE EFFECTS OF DHA ON RATS MEMORY | |
TH14574A (th) | สารผสมทางเภสัชกรรม | |
SU1774660A1 (ru) | Способ получения меченного тритием простагландина f | |
TH13475A (th) | สูตรผสมทางเภสัชกรรม |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB1A | Laying open of patent application |
Effective date: 19920114 |
|
FG3A | Patent granted, date of granting |
Effective date: 19981002 |
|
MM4A | Annulment/lapse due to non-payment of fees, searched and examined patent |
Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20131002 |